AI Article Synopsis

  • The study analyzed TTV load in 237 hepatitis C patients, including those with liver cancer, using real-time PCR.
  • Among the patients, 8% tested negative for TTV, with 37% showing low viral load and 56% high viral load.
  • High TTV viremia was linked to older age, previous blood transfusions, cirrhosis, and was identified as an independent risk factor for developing hepatocellular carcinoma, suggesting its potential significance in chronic liver disease prognosis.

Article Abstract

The TT virus (TTV) load was estimated in sera obtained from 237 patients with hepatitis C virus (HCV)-related chronic liver disease including 42 patients with hepatocellular carcinoma (HCC), by real-time detection PCR using primers and a probe derived from the well-conserved untranslated region of the TTV genome, which can detect all known TTV genotypes. Of the 237 patients studied, 18 (8%) were negative for TTV DNA, 87 (37%) had low TTV viremia (1.3 x 10(2)-9.9 x 10(3) copies/ml), and 132 (56%) had high TTV viremia (1.0 x 10(4)-2.1 x 10(6) copies/ml). Various features were compared between the patients with high TTV load (n = 132) and those with no TTV viremia or low viral load (n = 105). High TTV viremia (> or =10(4) copies/ml) was significantly associated with higher age (P < 0.05), past history of blood transfusion (P < 0.001), complication of cirrhosis (P < 0.05) or HCC (P < 0.0005), lower HCV RNA titer (P < 0.05), and lower platelet count (P < 0.01). On multivariate logistic regression analysis, high TTV viral load was a significant risk factor for HCC (P < 0.05), independent from known risk factors such as complication of liver cirrhosis (P < 0.0001) and high age (> or =65 years, P < 0.05), among all 237 patients. Furthermore, high TTV viral load was an independent risk factor for HCC among the 90 cirrhotic patients (P < 0.05). These results suggest that a high TTV viral load is associated independently with the complication of HCC and may have prognostic significance in patients with HCV-related chronic liver disease, although whether high TTV viremia mediates the progression of HCV-related chronic liver disease remains to be defined.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.10129DOI Listing

Publication Analysis

Top Keywords

high ttv
28
ttv viremia
20
chronic liver
16
liver disease
16
viral load
16
ttv
13
237 patients
12
hcv-related chronic
12
ttv viral
12
high
9

Similar Publications

Anelloviruses and Cancer.

J Infect Dis

December 2024

San Diego Supercomputer Center, University of California, San Diego, California, USA.

Anelloviruses are among the most prevalent viruses within the human virome, detected in over 90% of healthy individuals. Despite their ubiquity, the role of anelloviruses in human health remains elusive. This review examines the potential associations of anelloviruses torque teno virus (TTV), torque teno midi virus (TTMDV), and torque teno mini virus (TTMV) with various cancers, highlighting the mixed conclusions from current epidemiological studies.

View Article and Find Full Text PDF

High-load and low-volume warm-up increases performance in a resistance training session.

J Bodyw Mov Ther

October 2024

School of Physical Education and Sports, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; LADTEF - Performance, Training, and Physical Exercise Laboratory, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Introduction: A warm-up is recommended prior to performing a resistance training workout. Understanding the dose-response effect of warm-up load intensities can contribute to subsequent workout performance. The aim of this study was to compare different warm-up load intensities on subsequent resistance training volume in a workout.

View Article and Find Full Text PDF

Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases.

Radiology

November 2024

From the Département d'Imagerie, Gustave Roussy, Université Paris Saclay, 114 Rue Edouard Vaillant, 94805 Villejuif, France (L.D., S.A., J.H., S. Morer, C.D., F. Bidault, C.B., S. Muller, N.L.); Laboratoire d'Imagerie Biomédicale Multimodale Paris-Saclay (BioMAPS), Université Paris-Saclay, Inserm, Centre national de la recherche scientifique, Commissariat à l'Énergie Atomique, Villejuif, France (Y.B., L. Lawrance, O.G., S.A., F.W., F. Bidault, C.B., N.L.); OPtimisation Imagerie et Santé (OPIS), Inria, CentraleSupélec, Université Paris-Saclay, Gif-Sur-Yvette, France (Y.B., H.T.); Departments of Medical Biology and Pathology (D.V., L. Lacroix, E.R.), Cancer Medicine (M.A., M.S., S. Moog, M.F.M., M.T., A.B.T., B.V., N.A., B.B., F.A., F. Barlesi), Hematology (J.B.M.), and Genetics (O.C.), Gustave Roussy, Villejuif, France; Departments of Imaging (M.K.) and Medical Oncology (A.I.), Institut Bergonié, Bordeaux, France; Département d'Innovation Thérapeutique et des Essais Précoce, Gustave Roussy, Villejuif, France (A.B., L.B., C.N., A. Geraud, M.S., F.B.D., C.S., A. Gazzah, A.H., Y.L., S.P., A.I.); Oncostat, Inserm, Paris-Saclay University, labeled Ligue Contre le Cancer, Villejuif, France (A.B.); Mathématiques et Informatique pour la Complexité et les Systèmes (MICS), CentraleSupélec, Université Paris-Saclay, Gif-Sur-Yvette, France (P.H.C.); Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris, France (A.B., B.B., F.A., J.C.S., F. Barlesi, N.L.); Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark (L.B.); Gustave Roussy, Villejuif, France (J.C.S.); and Guerbet Research, Villepinte, France (L. Lawrance).

Background Tumor fraction (TF) at liquid biopsy is a potential noninvasive marker for tumor burden, but validation is needed. Purpose To evaluate TF as a potential surrogate for tumor burden, assessed at contrast-enhanced CT across diverse metastatic cancers. Methods This retrospective monocentric study included patients with cancer and metastatic disease, with TF results and contemporaneous contrast-enhanced CT performed between January 2021 and January 2023.

View Article and Find Full Text PDF

Objectives: Total tumor volume (TTV) is associated with overall and recurrence-free survival in patients with colorectal cancer liver metastases (CRLM). However, the labor-intensive nature of such manual assessments has hampered the clinical adoption of TTV as an imaging biomarker. This study aimed to develop and externally evaluate a CRLM auto-segmentation model on CT scans, to facilitate the clinical adoption of TTV.

View Article and Find Full Text PDF

Background: Somatostatin receptor (SSR) targeting radiotracer Ga-DOTATATE is used for Positron Emission Tomography (PET)/Computed Tomography (CT) imaging to assess patients with Pheochromocytoma and paraganglioma (PPGL), rare types of Neuroendocrine tumor (NET) which can metastasize thereby becoming difficult to quantify. The goal of this study is to develop an artificial intelligence (AI) model for automated lesion segmentation on whole-body 3D DOTATATE-PET/CT and to automate the tumor burden calculation. 132 Ga-DOTATATE PET/CT scans from 38 patients with metastatic and inoperable PPGL, were split into 70, and 62 scans, from 20, and 18 patients for training, and test sets, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!